Key result
Tight blood pressure control is linked to PRES prevention in pediatric SCD patients undergoing HSCT.
Why the study?
Does tight blood pressure control prevent PRES in pediatric SCD patients undergoing HSCT?
Does tight blood pressure control prevent PRES in pediatric SCD patients undergoing HSCT?
Tight blood pressure control is discussed as a potential strategy for preventing PRES in pediatric patients with sickle cell disease undergoing HSCT.
Answers are grounded in this paper and cite their sources.
Tight BP control may prevent PRES in pediatric SCD HSCT; leaves open need for prospective confirmation before practice change.
To the Editor,Posterior reversible encephalopathy syndrome (PRES) is a serious neurologic complication of hematopoietic stem cell transplantation (HSCT), particularly in pediatric patients with sic...
No takes yet. Share an insight, caveat, or question.
Rao et al. (2026) studied this question. Tight blood pressure control is associated with the prevention of posterior reversible encephalopathy syndrome (PRES) in pediatric sickle cell disease patients undergoing HSCT.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: